et al. Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C. Sci. Rep.6, 22995; doi: 10.1038/srep22995 (2016). This evidence concerns the gene IFNG and chronic hepatitis C virus infection.